Sigilon Therapeutics Inc. (SGTX)
NASDAQ: SGTX
· Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM
Sigilon Therapeutics Revenue
Sigilon Therapeutics reported an annual revenue of $12.94M, reflecting a 34.85% growth. For the quarter ending June 30, 2023, Sigilon Therapeutics generated $5.9M in revenue.
Revenue (ttm)
12.94M
Revenue Growth
34.85%
Price / Sales Ratio
11.39
Revenue / Employee
208.77K
Employees
62
Market Cap
56.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 12.94M | +34.85% |
| Dec 31, 2021 | 9.6M | -28.23% |
| Dec 31, 2020 | 13.37M | -5.52% |
| Dec 31, 2019 | 14.15M | +205.26% |
| Dec 31, 2018 | 4.64M | n/a |